PharmaregUAE
Early access

Early access and named patient programs.

When a critical medicine is not yet registered in the UAE, the law provides a pathway. We operate it end to end, from authority approval to licensed importation and delivery.

Authority approvals managed Importation under our own licences GDP-compliant medical warehouse

How the pathway works.

For medicines not yet registered in the UAE, the authorities permit supply in accordance with UAE laws and regulations, upon formal requests made by licensed physicians and institutions. Pharmareg manages the entire program on behalf of the institution and the manufacturer.

From formal request to delivery.

Four steps, one accountable team, with the licences already in place at every step that needs them.

01

Formal request

The licensed physician or institution submits a formal request for the required medicine, which we prepare and structure with the complete supporting documentation.

02

Authority approval

We manage the application with the relevant health authority through to the approval that permits the supply.

03

Licensed importation

The medicine is imported under our own licences with EDE import permits, and handled through our GDP-compliant licensed medical warehouse.

04

Delivery and documentation

Controlled delivery to the requesting institution, with full traceability and documentation maintained throughout.

Institutions and manufacturers.

Hospitals and clinics requiring unregistered critical medicines Institutions managing individual treatment needs Manufacturers whose products are not yet registered in the UAE

One accountable, licensed chain.

01 · Licensed infrastructure, not a broker

Our own importer credentials, EDE permits, and licensed medical warehouse mean the medicine moves through one accountable, compliant chain.

02 · Speed where it matters

We run the request, the approval, and the importation as one workstream with a single point of contact.

03 · A bridge to registration

For manufacturers, early access demand is often the first step toward full registration, which our regulatory team handles under the same roof.

Enquire about an early access program.

Tell us the medicine and the requesting institution, and we will confirm the pathway.

Talk to our team